Table:
begin	end	state
1	23	signal peptide
24	211	non-cytoplasmic
212	235	transmembrane
236	241	cytoplasmic
242	261	transmembrane
262	266	non-cytoplasmic
267	287	transmembrane
288	299	cytoplasmic
300	321	transmembrane
322	348	non-cytoplasmic
349	368	transmembrane
369	400	cytoplasmic
401	419	transmembrane
420	431	non-cytoplasmic
432	458	transmembrane
459	465	cytoplasmic
466	485	transmembrane
486	500	non-cytoplasmic

Input:
>Pf6N2E2_3548
MPTALYRLILALVLLLPLEAHAGDAEDFVAANPTQQAKLLETWAAQPEPERVELINALQQ
GQLTVDGQPKTLRLNNRLRGLIETALASHQLLAVDARVRLGAAQQLQKTARPAQLAFLDR
QLAGEQDEDVHAALSLALANLQLVDTNPNVRLAAVRLLGETGDPLARTRLEGLLEPGVET
DANVRTAAETSLAQVKRKLLVGELLGQAFSGMSLGSILLLAALGLAITFGLLGVINMAHG
EMLMLGAYSTYVVQMLFQRFAPNAIEFYPLIALPVAFFITAAIGMALERTVIRHLYGRPL
ETLLATWGISLMLIQLVRLVFGAQNVEVANPAWLSGGIQVLPNLVLPYNRIVIIAFALFV
VVLTWLLLNKTRLGLNVRAVTQNRNMAACCGVPTGRVDMLAFGLGSGIAGLGGVALSQIG
NVGPDLGQSYIIDSFLVVVLGGVGQLAGSVFAAFGLGIANKILEPQIGAVLGKILILALI
ILFIQKRPQGLFALKGRVID

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server